Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer

Evidence-based Complementary and Alternative Medicine : ECAM
Xinkui LiuXiaomeng Zhang

Abstract

Hedyotis diffusa Willd. (HDW) is one of the renowned herbs often used in the treatment of gastric cancer (GC). However, its curative mechanism has not been fully elucidated. To systematically investigate the mechanisms of HDW in GC. A network pharmacology approach mainly comprising target prediction, network construction, and module analysis was adopted in this study. A total of 353 targets of the 32 bioactive compounds in HDW were obtained. The network analysis showed that CA isoenzymes, p53, PIK3CA, CDK2, P27Kip1, cyclin D1, cyclin B1, cyclin A2, AKT1, BCL2, MAPK1, and VEGFA were identified as key targets of HDW in the treatment of GC. The functional enrichment analysis indicated that HDW probably produced the therapeutic effects against GC by synergistically regulating many biological pathways, such as nucleotide excision repair, apoptosis, cell cycle, PI3K/AKT/mTOR signaling pathway, VEGF signaling pathway, and Ras signaling pathway. This study holistically illuminates the fact that the pharmacological mechanisms of HDW in GC might be strongly associated with its synergic modulation of apoptosis, cell cycle, differentiation, proliferation, migration, invasion, and angiogenesis.

References

Sep 1, 1992·Gastroenterology·F ImazekiK Isono
Dec 1, 1966·Psychometrika·G Sabidussi
Mar 9, 1995·Nature·D O Morgan
Oct 1, 1996·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·A J Whitmarsh, R J Davis
Apr 10, 1999·Genes & Development·W L de LaatJ H Hoeijmakers
Dec 3, 1999·Science·T Lindahl, R D Wood
Sep 23, 2000·Nature·P Carmeliet, R K Jain
May 3, 2001·Nature·H JeongZ N Oltvai
Mar 21, 2002·Nature Reviews. Cancer·M Malumbres, M Barbacid
May 9, 2002·Molecular and Cellular Biology·Bangyan StilesHong Wu
Aug 23, 2002·Pharmacology & Therapeutics·Michelle M Hill, Brian A Hemmings
Aug 30, 2002·Journal of Cancer Research and Clinical Oncology·Mitsuhiro YasudaDaisuke Korenaga
Jan 15, 2003·BMC Bioinformatics·Gary D Bader, Christopher W V Hogue
Mar 23, 2004·Cancer Biology & Therapy·Alfonso BellacosaLionel Larue
May 12, 2004·Current Cancer Drug Targets·Constantine S MitsiadesMichael Koutsilieris
Dec 21, 2004·Nucleic Acids Research·Ada HamoshVictor A McKusick
Jan 6, 2005·World Journal of Gastroenterology : WJG·Antti-J KiveläSeppo Parkkila
Mar 24, 2005·BMC Cancer·Vivian Sze Wing LiSuet Yi Leung
Oct 26, 2005·Journal of Gastroenterology and Hepatology·George K AnagnostopoulosNiki J Agnantis
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna D WagnerWolfgang E Fleig
Mar 24, 2007·Nature Reviews. Molecular Cell Biology·Karen H Vousden, David P Lane
Oct 9, 2007·Nature Biotechnology·Andrew L Hopkins
Oct 18, 2007·Molecular Systems Biology·Han-Yu ChuangTrey Ideker
Nov 14, 2007·Bioorganic & Medicinal Chemistry Letters·Lorna PiazziAngela Rampa
Feb 22, 2008·Current Cancer Drug Targets·Eriko TokunagaYoshihiko Maehara
Apr 24, 2008·Nature Reviews. Molecular Cell Biology·Todd RileyArnold Levine
Nov 11, 2008·Current Medicinal Chemistry·Musiliyu A MusaM Omar F Khan
Jan 10, 2009·Nature Protocols·Da Wei HuangRichard A Lempicki
Feb 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guanzhen YuKeping Xie
Feb 25, 2009·Nature Reviews. Cancer·Marcos Malumbres, Mariano Barbacid
Jan 19, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Seppo ParkkilaMarkku Miettinen
May 19, 2010·Mutation Research·Ilse DecordierMicheline Kirsch-Volders
Aug 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M EkströmR Bellocco
Aug 25, 2010·IEEE/ACM Transactions on Computational Biology and Bioinformatics·Jianxin WangYi Pan

❮ Previous
Next ❯

Citations

Feb 7, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Qing LuoYang Liu
May 8, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Tianqi WangZhenguo Wang
Jul 24, 2021·Carbohydrate Polymers·Zuobing XiaoXingran Kou

❮ Previous
Next ❯

Software Mentioned

NetworkAnalyzer
DigSee
Cytoscape
PharmGKB
Search Tool for the Retrieval
Cytoscape Molecular Complex Detection ( MCODE )
MCODE

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.